Commonly reported molecular targets in chordoma include platelet derived growth factor (PDGFR), vascular endothelial growth factor receptor (VEGFR), and epidermal growth factor receptor (EGFR), insulin-like growth factors (IGF), and mammalian target of rapamycin (mTOR). This evidence concerns the gene MTOR and chordoma.